The Conversation (0)
Promedior Inc., a biotechnology company focused on developing biological theraepeutics to treat fibrotic diseases, announced that it has opened its new office and laboratory in Lexington, Massachusetts.
Promedior Inc., a biotechnology company focused on developing biological theraepeutics to treat fibrotic diseases, announced that it has opened its new office and laboratory in Lexington, Massachusetts.
As quoted in the press release:
Consolidating all of its operations, the new facility will serve as the company’s headquarters and completes the corporate move from the suburbs of Philadelphia, Pennsylvania. Promedior’s new facility includes state-of-the-art laboratories to support product development and commercialization of the company’s novel Pentraxin-2 therapeutics to treat fibrosis, including a number of rare diseases such as idiopathic pulmonary fibrosis (IPF) and myelofibrosis.